about
Mutational analysis of angiogenin gene in Parkinson's disease.Lovastatin protects neurite degeneration in LRRK2-G2019S parkinsonism through activating the Akt/Nrf pathway and inhibiting GSK3β activity.Reaffirmation of GAK, but not HLA-DRA, as a Parkinson's disease susceptibility gene in a Taiwanese population.Analysis of Lrrk2 R1628P as a risk factor for Parkinson's disease.A novel neuropsychiatric phenotype of KCNJ2 mutation in one Taiwanese family with Andersen-Tawil syndrome.Mutational analysis of FBXO7 gene in Parkinson's disease in a Taiwanese population.Non-synonymous GIGYF2 variants in Parkinson's disease from two Asian populations.The design, synthesis and biological evaluation of 7-alkoxy-4-heteroarylamino-3-cyanoquinolines as dual inhibitors of c-Src and iNOS.Lack of TMEM230 mutations in patients with familial and sporadic Parkinson's disease in a Taiwanese population.Lack of RAB39B mutations in early-onset and familial Parkinson's disease in a Taiwanese cohort.RIT2 variant is not associated with Parkinson's disease in a Taiwanese population.BST1 rs11724635 interacts with environmental factors to increase the risk of Parkinson's disease in a Taiwanese population.Lrrk2 S1647T and BDNF V66M interact with environmental factors to increase risk of Parkinson's disease.Multiple LRRK2 variants modulate risk of Parkinson disease: a Chinese multicenter study.LRRK 2 gene mutations in the pathophysiology of the ROCO domain and therapeutic targets for Parkinson's disease: a review.COQ2 p.V393A variant, rs148156462, is not associated with Parkinson's disease in a Taiwanese population
P50
Q34489349-2B8EBC5C-7472-4E0A-A1CF-AA043CFF742EQ35941717-EFAEDBFA-F4FF-44B3-989C-C5CBCA7B7D4AQ39349735-4994C255-A7D2-4362-A629-2F2357BD577FQ40102731-52DF767D-03CB-4D1D-8DB7-FFAC73079DDAQ43181269-DE1BD2FE-35D3-4EE5-9E9B-FD047A75F206Q46011426-CAFCBE92-4DA5-47F4-80AD-0688277FF621Q46239598-D3AA1086-739D-4B6B-80B0-9226BB170DEFQ46310263-3EB2F4B9-231E-46E0-98C1-57B782AEFB1DQ48000758-B48D3CE3-10A1-4F71-97BD-109E7A95B532Q48432323-925D7E5A-2582-4B60-9FAE-678943FE83E4Q51026815-43417D71-C2EE-4E80-A946-99D977F1D2FEQ54433952-E282B773-BC55-4477-95D7-F5BE2FE6233AQ54625979-8E36A168-FD29-452E-B2B4-1DA3E4A360A9Q54690286-625A2505-1ADF-42F9-9F21-BFC9192CDCE2Q55410950-100E39F2-4BDF-4469-8A1A-7BAFDAAD7383Q85272636-63D768DC-A58C-43AD-B1DD-82A17EF69D79
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Meng-Ling Chen
@ast
Meng-Ling Chen
@en
Meng-Ling Chen
@es
Meng-Ling Chen
@sl
type
label
Meng-Ling Chen
@ast
Meng-Ling Chen
@en
Meng-Ling Chen
@es
Meng-Ling Chen
@sl
prefLabel
Meng-Ling Chen
@ast
Meng-Ling Chen
@en
Meng-Ling Chen
@es
Meng-Ling Chen
@sl
P108
P31
P496
0000-0003-3980-5546